Cardio-HART for Commissioners:
Invest in Early Detection,
Save Lives and Costs

Spend Millions. Save Billions.

By deploying Cardio-HART for commissioners across NHS ICS/ICBs or regional healthcare systems, a one-time investment prevents billions in downstream costs:

  • Echo Referral Reduction: Up to 50% of primary‑care echo referrals are unnecessary1.
  • Cost avoidance: Saved echo costs (~£80–£100 each) and reduced emergency admissions.
  • Early intervention ROI: Detecting and treating heart failure early prevents expensive hospitalisation—costing ~£4,000 per acute HF admission2.

Immediate & Long-Term Impact

Why Cardio-HART for commissioners Delivers ROI

1. Cut Low-Value Testing

  • ~50% of echo referrals from GPs may be unnecessary—Cardio‑HART filters these, saving echo slots and cutting costs.
  • NT‑proBNP underused: fewer than 20% are tested, contributing to high downstream echo use3.

2. Prevent Crisis Care

  • 75% of HF diagnoses occur in hospital. Delayed diagnosis triggers costly A&E admissions—avoidable with early testing4.
  • One avoided HF hospitalisation offsets the cost of Cardio‑HART testing for hundreds of patients.

3. Promote Health Equity

  • Echo services are concentrated in urban hospital settings.
  • Rural and underserved areas get equitable access via local GP-based Cardio‑HART.
  • Trial data shows 4‑fold variation in echo access across regions5.

Environmental & Social Co‑Benefits

  • Healthcare travel equals ~17% of NHS carbon emissions6.
  • Each transthoracic echo emits ~1 kg CO₂e—inclusive of travel, power, and equipment7.
  • Scaling Cardio‑HART could reduce community echo volume by 100,000s/year—cutting CO₂ and supporting NHS Net Zero.
Grandmother embraced by granddaughter, symbolizing patient-centred cardiac care with Cardio-HART for commissioners
Grandmother and granddaughter smiling together, showing patient-centred care with Cardio-HART for commissioners

Patient-Centred Care—No Trade-Offs

Cardio‑HART is patient-focused and system-smart:

  • Convenient: Simple GP-based test with no hospital visit
  • Rapid: All results in under 10 minutes—allowing same-day decisions
  • Accurate: 96% agreement with echocardiography for key conditions
  • Lower burden: Fewer hospital visits ease stress on families

Public Health, Regional, and National Goals Alignment

  • Supports NHS Long Term Plan: earlier HF diagnosis, reduced low‑value diagnostics.
  • Meets Diagnostics Recovery & Renewal objectives for better capacity use.
  • National climate targets: aligns with NHS net zero by reducing travel and imaging footprint.

Summary Table

ChallengeCardio‑HART SolutionImpact
Overloaded echo servicesFrontline ECG+AI with echo-level insightsSave echo capacity for complex cases
Late diagnosis in A&EEarly detection in primary careReduce acute admissions
Urban–rural inequityPortable GP-based testingFairer, local access
CO₂ from travel & imagingFewer referrals and scansSupports NHS carbon targets
High downstream costsFewer unnecessary tests & hospitalisationsMulti-million £ savings/year
Business meeting between healthcare decision-makers discussing Cardio-HART’s cost-effectiveness and implementation strategy.

The Bottom Line

A modest investment in Cardio‑HART transforms cardiac care at low cost:

  • Better, earlier diagnosis
  • Lower system-wide costs
  • Healthier, happier patients
  • Progress toward carbon neutrality

If you’d like to understand potential ROI for your ICS region or Spain’s regional health authority, just ask—we’ll run the numbers.

Download your PowerPoint for commissioners in England or Spanish healthcare decision-makers!

Download PowerPoint (UK & Spain)

Let’s Discuss How Cardio-HART Fits Into Your Regional Strategy

Contact us to explore clinical data, cost-effectiveness, and implementation options tailored to your area.

References & Data Sources

  1. NICE pilot: Echo referrals fell from 39% to 32% post NT‑proBNP use³. ↩︎
  2. HF Report: ~£4,000 per acute HF hospital admission⁴. ↩︎
  3. Only 18.9% of patients had NT‑proBNP tested—leading to many echo referrals⁴. ↩︎
  4. 75% of HF patients diagnosed in hospital; nearly 50% via A&E⁴. ↩︎
  5. Echo use varies 4-fold between urban vs rural regions in Australia⁵. ↩︎
  6. Patient travel accounts for ~17% of NHS carbon emissions⁶. ↩︎
  7. CO₂e per echo = 0.5–2 kg; echo is lowest among imaging but not zero⁷. ↩︎